Trademark: 85332661
Status Date
Monday, July 29, 2013
Filing Date
Friday, May 27, 2011
Published for Opposition
Tuesday, November 1, 2011
Abandoned Date
Monday, July 29, 2013
42 Medical and scientific research, namely, conducting clinical trials; conducting clinical trials for testing the safety and effectiveness of rituximab and lenalidomide
Jul 29, 2013
Abandonment Notice Mailed - No Use Statement Filed
Jul 29, 2013
Abandonment - No Use Statement Filed
Nov 17, 2012
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2012
Extension 2 Granted
Nov 14, 2012
Extension 2 Filed
Nov 15, 2012
Case Assigned To Intent To Use Paralegal
Nov 14, 2012
Teas Extension Received
Jun 12, 2012
Notice Of Approval Of Extension Request E-Mailed
Jun 8, 2012
Extension 1 Granted
Jun 8, 2012
Extension 1 Filed
Jun 8, 2012
Teas Extension Received
Dec 27, 2011
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2011
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2011
Published For Opposition
Sep 27, 2011
Law Office Publication Review Completed
Sep 26, 2011
Assigned To Lie
Sep 14, 2011
Approved For Pub - Principal Register
Sep 14, 2011
Examiner's Amendment Entered
Sep 14, 2011
Notification Of Examiners Amendment E-Mailed
Sep 14, 2011
Examiners Amendment E-Mailed
Sep 14, 2011
Examiners Amendment -Written
Sep 13, 2011
Notification Of Non-Final Action E-Mailed
Sep 13, 2011
Non-Final Action E-Mailed
Sep 13, 2011
Non-Final Action Written
Sep 13, 2011
Assigned To Examiner
Jun 2, 2011
New Application Office Supplied Data Entered In Tram
May 31, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
